Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 13;16(4):600.
doi: 10.3390/v16040600.

Clinical Evaluation of the BIOFIRE SPOTFIRE Respiratory Panel

Affiliations

Clinical Evaluation of the BIOFIRE SPOTFIRE Respiratory Panel

Wai-Sing Chan et al. Viruses. .

Abstract

The BIOFIRE SPOTFIRE Respiratory (R) Panel is a novel, in vitro diagnostic PCR assay with 15 pathogen targets. The runtime is about 15 min which is the shortest among similar panels in the market. We evaluated the performance of the SPOTFIRE R Panel with 151 specimens, including 133 collected from the upper respiratory tract (URT), 13 from the lower respiratory tract (LRT) and 5 external quality assessment program (EQAP) samples. The respiratory specimens were enrolled throughout the first two post-COVID-19 influenza seasons in Hong Kong (March to December 2023). For URT specimens, full concordance was observed between the SPOTFIRE R Panel and the standard-of-care FilmArray Respiratory 2.1 plus Panel (RP2.1plus) for 109 specimens (109/133, 81.95%). After discrepant analysis, the SPOTFIRE R Panel identified more pathogens than the RP2.1plus in 15 specimens and vice versa in 3 specimens. The per-target negative and positive percentage agreement (NPA and PPA) were 92.86-100% except the PPA of adenovirus (88.24%). For LRT and EQAP samples, all results were fully concordant. To conclude, the performance of the SPOTFIRE R Panel was comparable to the RP2.1plus.

Keywords: BIOFIRE; FilmArray; PCR; SARS-CoV-2; SPOTFIRE; TORCH; flu; respiratory.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Comparison between FilmArray Respiratory 2.1 plus Panel (RP2.1plus) and SPOTFIRE Respiratory (R) Panel. The images are acquired from the website of BIOFIRE Diagnostics (Salt Lake City, UT, USA). MERS-CoV, Middle East respiratory syndrome coronavirus; RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; ✓, available; ✗, not available.

References

    1. Department of Health, Hong Kong Health Facts of Hong Kong, 2023 Edition. [(accessed on 18 January 2024)]; Available online: https://www.dh.gov.hk/english/statistics/statistics_hs/files/2023.pdf.
    1. Centre for Health Protection, Department of Health, The Government of the Hong Kong Special Administrative Region. [(accessed on 18 January 2024)]; Available online: https://www.chp.gov.hk/en/statistics/data/10/27/380.html.
    1. Jin X., Ren J., Li R., Gao Y., Zhang H., Li J., Zhang J., Wang X., Wang G. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. eClinicalMedicine. 2021;37:100986. doi: 10.1016/j.eclinm.2021.100986. - DOI - PMC - PubMed
    1. United Nations Shared Responsibility, Global Solidarity: Responding to the Socio-Economic Impacts of COVID-19. [(accessed on 20 January 2024)]. Available online: https://en.unesco.org/inclusivepolicylab/sites/default/files/publication....
    1. Gill P.J., Ashdown H.F., Wang K., Heneghan C., Roberts N.W., Harnden A., Mallett S. Identification of children at risk of influenza-related complications in primary and ambulatory care: A systematic review and meta-analysis. Lancet Respir. Med. 2015;3:139–149. doi: 10.1016/S2213-2600(14)70252-8. - DOI - PubMed

Publication types

MeSH terms